Condition: Atrial Fibrillation · Oral Anticoagulation · Stroke · Sponsor: Javelin Medical
Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral vessel occlusion (LVO). This randomized control trial aims to address this unmet need by testing whether use of bilateral carotid filter implants in addition to OAC will reduce the risk of stroke in AF patients with recent (e.g. within 12 months) ischemic stroke vs. only OAC.
This description comes directly from the study's public registry record.
Sagit Broder, MSc · +972587112116 · sagit@javelinmed.com
Jessica Tyrwhitt · intercept@worldhealthresearch.ca
Always discuss trial participation with your own doctor first.
| Mercyhealth Javon Bea Hospital - Riverside | Rockford, Illinois, United States | Recruiting |
| Weill Cornell Medical Center | New York, New York, United States | Recruiting |
| Erlanger Medical Center | Chattanooga, Tennessee, United States | Recruiting |
| Methodist University Hospital | Memphis, Tennessee, United States | Active Not Recruiting |
| Baptist Memorial Hospital-Memphis | Memphis, Tennessee, United States | Active Not Recruiting |
| Hamilton General Hospital | Hamilton, Canada, Canada | Recruiting |
| University Hospital | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05723926